Medical therapy of malignant hypertension. 1957

J W MURI

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006974 Hypertension, Malignant A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. Malignant Hypertension
D001337 Autonomic Agents Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc. Autonomic Drugs,Autonomic Effect,Autonomic Effects,Agents, Autonomic,Drugs, Autonomic,Effect, Autonomic,Effects, Autonomic

Related Publications

J W MURI
September 1954, Revista medica de Chile,
J W MURI
April 1959, Revista de la Asociacion Medica Argentina,
J W MURI
September 1972, Nederlands tijdschrift voor geneeskunde,
J W MURI
May 1954, Wiener medizinische Wochenschrift (1946),
J W MURI
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
J W MURI
March 1956, Nordisk medicin,
J W MURI
January 1965, Duodecim; laaketieteellinen aikakauskirja,
J W MURI
August 1962, Deutsches medizinisches Journal,
J W MURI
January 1977, Godisen zbornik na Medicinskiot fakultet vo Skopje,
Copied contents to your clipboard!